McLean Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
McLean Asset Management's AMGN Position: Q3 2026 in Review
McLean Asset Management reduced its Amgen (AMGN) stake by 1% in Q3 2026, selling an estimated $4.38K and leaving 1,053 shares worth $485K. The position accounts for 0.06% of the portfolio, ranked #106.
McLean Asset Management first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- McLean Asset Management held 1,053 shares of Amgen worth $485K as of Q3 2026.
- McLean Asset Management sold 11 Amgen shares in Q3 2026, an estimated $4.38K.
- Amgen made up 0.06% of McLean Asset Management's portfolio in Q3 2026, its #106 holding.
- McLean Asset Management first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on McLean Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.